Role of organic cation transporters in drug-induced toxicity

被引:76
作者
Ciarimboli, Giuliano [1 ]
机构
[1] Univ Klinikum Munster, Med Klin & Poliklin D, D-48149 Munster, Germany
关键词
cisplatin; metformin; organic cation transporters; toxicity; TOXIN EXTRUSION 1; PH-DEPENDENT TRANSPORT; FUNCTIONAL-CHARACTERIZATION; HUMAN MULTIDRUG; GENETIC-VARIATION; CISPLATIN NEPHROTOXICITY; ANION TRANSPORTERS; MOLECULAR-CLONING; TUBULAR SECRETION; RENAL CLEARANCE;
D O I
10.1517/17425255.2011.547474
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Introduction: Membrane transporters are important determinants of in vivo drug disposition, therapeutic efficacy and adverse drug reactions. Many commonly used drugs are organic cations and substrates of organic cation transporters (OCTs). These transporters have a large binding site containing partially overlapping interaction domains for different substrates and are specifically distributed around the body. Consequently, drug interactions with these transporters can result in specific toxicity. Areas covered: This review describes the general properties of OCT and illustrates their importance for the development of important drug toxicities using the examples of metformin and cisplatin. Additionally, this review discusses the role of OCT polymorphisms in the modulation of these toxic effects. Expert opinion: Understanding how drugs interact with membrane transporters is pivotally important in explaining the mechanisms of specific toxicities and also in designing new drugs or new therapeutic protective protocols by specific competition at the transporter. Defining the pharmacogenomics of these transporters will be essential to personalized medicine, enabling physicians to choose drugs for patients based on efficacy, availability, cost, safety, tolerability and convenience.
引用
收藏
页码:159 / 174
页数:16
相关论文
共 144 条
[1]
Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice [J].
Baganz, Nicole L. ;
Horton, Rebecca E. ;
Calderon, Alfredo S. ;
Owens, W. Anthony ;
Munn, Jaclyn L. ;
Watts, Lora T. ;
Koldzic-Zivanovic, Nina ;
Jeske, Nathaniel A. ;
Koek, Wouter ;
Toney, Glenn M. ;
Daws, Lynette C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (48) :18976-18981
[2]
The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization [J].
Barendt, WM ;
Wright, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22491-22496
[3]
Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study [J].
Becker, Matth S. L. ;
Visser, Loes E. ;
van Schaik, Ron H. N. ;
Hofman, Albert ;
Uitterlinden, Andre G. ;
Stricker, Bruno H. Ch. .
DIABETES, 2009, 58 (03) :745-749
[4]
Characterization of regulatory mechanisms and states of human organic cation transporter [J].
Biermann, J ;
Lang, D ;
Gorboulev, V ;
Koepsell, H ;
Sindic, A ;
Schröter, R ;
Zvirbliene, A ;
Pavenstädt, H ;
Schlatter, E ;
Ciarimboli, G .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (06) :C1521-C1531
[5]
Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3) [J].
Bourdet, DL ;
Pritchard, JB ;
Thakker, DR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1288-1297
[6]
Lactic acidosis rates in type 2 diabetes [J].
Brown, JB ;
Pedula, K ;
Barzilay, J ;
Herson, MK ;
Latare, P .
DIABETES CARE, 1998, 21 (10) :1659-1663
[7]
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2) [J].
Burger, H. ;
Zoumaro-Djayoon, A. ;
Boersma, A. W. M. ;
Helleman, J. ;
Berns, E. M. J. J. ;
Mathijssen, R. H. J. ;
Loos, W. J. ;
Wiemer, E. A. C. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (04) :898-908
[8]
Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine [J].
Busch, AE ;
Karbach, U ;
Miska, D ;
Gorboulev, V ;
Akhoundova, A ;
Volk, C ;
Arndt, P ;
Ulzheimer, JC ;
Sonders, MS ;
Baumann, C ;
Waldegger, S ;
Lang, F ;
Koepsell, H .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :342-352
[9]
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin [J].
Chen, Ligong ;
Pawlikowski, Bradley ;
Schlessinger, Avner ;
More, Swati S. ;
Stryke, Doug ;
Johns, Susan J. ;
Portman, Michael A. ;
Chen, Eugene ;
Ferrin, Thomas E. ;
Sali, Andrej ;
Giacomini, Kathleen M. .
PHARMACOGENETICS AND GENOMICS, 2010, 20 (11) :687-699
[10]
Renal organic cation and nucleoside transport [J].
Chen, R ;
Jonker, JW ;
Nelson, JA .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (02) :185-190